Captor Therapeutics ® Investor Relations

      Investor Relations

      Text of resolutions adopted by the Extraordinary General Meeting on 21 February 2021

      Publication date: 2022-02-21
      Number: RB ESPI 7/2022

      Current Report No. 7/2022

      Date of preparation: 21 February 2022

      Subject: Text of resolutions adopted by the Extraordinary General Meeting on 21 February 2021

      Legal basis: Article 56 sec. 1 point 2 of the Public Offering Act - current and periodical information

      The Management Board of Captor Therapeutics S.A. with its registered office in Wroclaw (the “Company”) encloses the text of resolutions passed by the Extraordinary General Meeting of the Company on 21 February 2021 (“EGM”). No objections to the resolutions were raised.

      Furthermore, the Company informs that since the EGM approved the co-optation of the Supervisory Board member appointed by the Supervisory Board – Robert Florczykowski, the EGM decided not to consider item. 6 of the EGM agenda (adopting a resolution on appointing a member of the Company's Supervisory Board).


      Attachments: